Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells

Fig. 6

CD5+ B cells significantly increase after hUC-MSC therapy. Populations of CD5+ B cells were identified as CD5+CD19+ by flow cytometry. Representative dot plots of CD5+ B cells in the spleen (a), mesenteric lymph node (MLN) (c), and peritoneal cavity (e) are shown. Data are presented as plots with P value (b, d and f). n = 9 for each group; * P < 0.05 vs. MSC-treated mice. hUC-MSC human umbilical cord-derived mesenchymal stem cell, TNBS trinitrobenzenesulfonic acid

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512